ARCHIVES

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

Estrogen Can Benefit Women With Metastatic Breast Cancer

January 30, 2009

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

In Brief: Ashworth Named Center Director at UCSF

March 21, 2014